Androluteoma syndrome of pregnancy.
The clinical course of a 26-year-old primigravid woman with a virilizing luteoma of pregnancy is described. It was demonstrated by endocrine studies that the tumor secreted an excessive amount of testosterone. After removal of the luteoma in week 32 of pregnancy, the virilizing symptoms of the mother completely regressed. A normal male infant was delivered in week 39. From 100 luteomas of pregnancy described in the literature, 26 cases have been cited to elicit endocrine virilizing activity. An evaluative synopsis indicates that including the case described in this paper only 13 can be regarded as a clinical, morphologic, and functional entity. This entity should be differentiated from the inhomogeneous group of luteomas as the "androluteoma syndrome of pregnancy." It is characterized by the following major criteria: virilization, beginning with the second trimester of pregnancy; histologic criteria of a luteoma of pregnancy; production of testosterone, leading to excessive plasma levels (exceeding the concentration of androstenedione), and masculinization of female fetuses.
D000152:Acne Vulgaris / Q000209:etiology; D000328:Adult; D000735:Androstenedione / Q000032:analysis; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000032:analysis / Q000175:diagnosis*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis* / Q000209:etiology; D013577:Syndrome; D013739:Testosterone / Q000032:analysis; D013798:Thecoma / Q000032:analysis / Q000175:diagnosis*; D014770:Virilism / Q000209:etiology*
D013739:Testosterone; D000735:Androstenedione